About MPRS BIOLOGICAL
MPRS BIOLOGICAL is a company based in Delhi (India) founded in 2014 by Manish Singh. It operates as a B2B and Distribution. MPRS BIOLOGICAL offers products and services including Cardiac Biomarkers, Haematology Analyzers, Electrolyte Analyzers, and Point of Care Devices.
- Headquarter Delhi, India
- Founders Manish Singh
- SectorsHealthcare
- Email••••••••
- Website mprsbio.net
- Legal Name Mprs Biological Private Limited
- Date of Incorporation 31 Mar, 2014
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹5.32 Cr
FY 2025 · -54% YoY
- Net Profit₹5.8 Lakh
FY 2025 · 1% margin
- EBITDA₹18.5 Lakh
FY 2025 · 3% margin
Associated legal entities of MPRS BIOLOGICAL
MPRS BIOLOGICAL operates through Mprs Biological Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mprs Biological Private Limited CIN U33110DL2014PTC267306 | Active | 31 Mar 2014 | New Delhi, Delhi | ₹5.3 Cr | – | 3 | View details |
Products & Services of MPRS BIOLOGICAL
MPRS BIOLOGICAL offers a comprehensive portfolio of products and services, including Cardiac Biomarkers, Haematology Analyzers, Electrolyte Analyzers, and Point of Care Devices.
Devices for detecting cardiac conditions in healthcare settings.
Analyzers for blood testing and diagnostics in medical facilities.
Tools for measuring electrolytes in clinical environments.
Portable devices for on-site diagnostic testing and monitoring.
Board of directors of Mprs Biological Private Limited (MPRS BIOLOGICAL)
Mprs Biological Private Limited is the primary company behind MPRS BIOLOGICAL. The board of Mprs Biological Private Limited currently have 3 directors; the longest-serving is Manish Singh, appointed in 2014. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manish Singh DIN 06798865 | Director | 31 Mar 2014 | 12 yrs 6 mo | Mprs Biological Private Limited |
| Sharad Singh DIN 07621047 | Director | 28 Sep 2016 | 10 yrs | Mprs Biological Private Limited |
| Rajesh Gupta DIN 07063648 | Director | 02 Jul 2020 | 6 yrs 3 mo | Mprs Biological Private Limited |
People of MPRS BIOLOGICAL
1 people are tracked at MPRS BIOLOGICAL (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder, Managing Director | Leadership |
Complete people profiles for MPRS BIOLOGICAL
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of MPRS BIOLOGICAL
Figures of Mprs Biological Private Limited, the primary company behind MPRS BIOLOGICAL, for FY 2025. Revenue was ₹5.32 Cr (-54% year on year). Net profit was ₹5.8 Lakh (1% margin). EBITDA was ₹18.5 Lakh (3% margin). Revenue has grown at a compounded annual rate of +27% over three years and +25% over five years.
- ₹5.32 CrRevenue · FY 2025 · -54% YoY
- ₹5.8 LakhNet profit · 1% margin
- ₹18.5 LakhEBITDA · 3% margin
- ₹8 LakhPaid-up capital
- +27%Revenue CAGR, 3 years
- +25%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mprs Biological Private Limited are on its company page.
Detailed financial statements for MPRS BIOLOGICAL
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of MPRS BIOLOGICAL
The website of MPRS BIOLOGICAL (mprsbio.net) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 128.5% vs previous month
Similar companies to MPRS BIOLOGICAL
10 companies that operate in the same segment as MPRS BIOLOGICAL (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MPRS BIOLOGICAL
MPRS BIOLOGICAL was founded in 2014.
MPRS BIOLOGICAL is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind MPRS BIOLOGICAL, Mprs Biological Private Limited, reported revenue of ₹5.32 Cr for FY 2025, down 54% year on year.
MPRS Biological Pvt. Ltd. imports advanced medical diagnostic tools from countries like the USA and Asia, distributing them through a network in India. They specialize in products such as cardiac biomarkers, haematology analyzers, and point-of-care devices, serving healthcare professionals and institutions. Based in New Delhi, they partner with global leaders to provide affordable, reliable solutions for diagnostics, toxicology, forensics, and genetics services.
MPRS BIOLOGICAL offers Cardiac Biomarkers, Haematology Analyzers, Electrolyte Analyzers, and Point of Care Devices.
MPRS BIOLOGICAL operates through Mprs Biological Private Limited.
The legal entities of MPRS BIOLOGICAL currently have 3 directors, including Manish Singh, Rajesh Gupta, Sharad Singh.